Characterization of the first FGFRL1 mutation identified in a craniosynostosis patient

Thorsten Rieckmann1, Lei Zhuang, Christa E Flück

  • 1Department of Clinical Research, University of Bern, 3010 Bern, Switzerland.

Insights

A novel mutation in Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) was found in a patient with skeletal malformations. This FGFRL1 mutation alters protein localization, likely contributing to congenital skeletal abnormalities.

Area of Science:

  • Genetics
  • Molecular Biology
  • Developmental Biology

Background:

  • Fibroblast growth factor receptor-like 1 (FGFRL1) is a transmembrane protein with largely unknown functions.
  • Mutations in related fibroblast growth factor receptors (FGFRs) are known to cause skeletal malformations.

Purpose of the Study:

  • To investigate the role of FGFRL1 in congenital skeletal malformations by searching for mutations.
  • To characterize the functional consequences of a identified FGFRL1 mutation in vitro.

Main Methods:

  • Screening of FGFRL1 in DNA samples from patients with congenital skeletal malformations and controls.
  • In vitro reporter gene assays to assess FGF signaling inhibition.
  • Subcellular localization studies of wild-type and mutant FGFRL1 proteins using microscopy.

Main Results:

  • A patient with craniosynostosis, radio-ulnar synostosis, and genital abnormalities (diagnosed with Antley-Bixler syndrome) was found to have a frameshift mutation in the FGFRL1 intracellular domain.
  • Both wild-type and mutant FGFRL1 inhibited FGF signaling in reporter gene assays.
  • Mutant FGFRL1 exhibited altered subcellular localization, predominantly residing at the plasma membrane, unlike wild-type FGFRL1 which localized to vesicular structures and the Golgi complex.
  • Specific intracellular motifs (tandem tyrosine-based and histidine-rich sequences) were identified as responsible for the differential localization of FGFRL1.

Conclusions:

  • The identified frameshift mutation in FGFRL1 is likely pathogenic and contributes to the patient's skeletal malformations.
  • Altered subcellular localization of FGFRL1 due to the mutation may disrupt normal FGF signaling pathways involved in skeletal development.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...